Strategic Growth Uniphar Development is expanding its U.S. presence with new leadership hires and office expansions, signaling increased capacity and readiness for larger-scale partnerships across Clinical, Regulatory, Medical, and Commercial services.

Full Lifecycle The company offers end-to-end biopharma development capabilities from early research through commercialization and beyond, presenting cross-sell opportunities to pharma, medtech, and biotech clients seeking integrated development and market access solutions.

Leadership Focus Recent appointments of a new President, Chief Medical Officer, and expanded senior leadership imply a strategic emphasis on clinical excellence, regulatory maturity, and operational transformation—opening doors for high-impact strategic collaborations and joint programs.

Global Reach With operations spanning 180 countries and a global team, Uniphar Development can support multinational clients requiring regulatory alignment, clinical operations, and distribution capabilities across diverse markets.

Financial Footing Revenue range of 50 to 100 million and a broad client base of over 200 multinational partners indicate a scalable platform for upsell into higher-value services such as advanced pharmacometrics, bioanalytical support, and comprehensive market access solutions.